22nd Century: FDA Catalyst

FDA announced a plan that positions 22nd Century to benefit with its low nicotine products that already meet the stated goals of the government organization.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.